JVMTX | PQNAX | JVMTX / PQNAX | |
Total Expense Ratio | 1.00 | 1.00 | 100% |
Annual Report Gross Expense Ratio | 1.11 | 1.12 | 99% |
Fund Existence | 12 years | 34 years | - |
Gain YTD | 6.429 | 1.968 | 327% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.2B | 592M | 3,750% |
Annual Yield % from dividends | 0.65 | 1.81 | 36% |
Returns for 1 year | -3.72 | 1.53 | -243% |
Returns for 3 years | 21.93 | -9.51 | -231% |
Returns for 5 years | 54.11 | 3.91 | 1,386% |
Returns for 10 years | 42.61 | 8.26 | 516% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SAGP | 32.89 | 0.16 | +0.49% |
Strategas Global Policy Opp ETF | |||
IWB | 343.04 | 1.27 | +0.37% |
iShares Russell 1000 ETF | |||
TOK | 126.70 | 0.32 | +0.25% |
iShares MSCI Kokusai ETF | |||
FFC | 16.50 | N/A | N/A |
Flaherty & Crumrine Preferred and Income Securities Fund | |||
BIS | 15.96 | -0.57 | -3.45% |
ProShares UltraShort Nasdaq Biotech |